The prevalence of COVID vaccine acceptance among pregnant women: A systematic review and meta-analysis DOI Creative Commons
Kurvatteppa Halemani, Sanjay Dhiraaj,

T Latha

et al.

Clinical Epidemiology and Global Health, Journal Year: 2022, Volume and Issue: 17, P. 101144 - 101144

Published: Sept. 1, 2022

COVID pandemic has massively hit every nook of the world. Millions people were infected and lost their lives to deadly pandemic. This novel virus destroyed essential healthcare service globally. Mass vaccination is only option halt transmission. study aimed estimate acceptance vaccine among pregnant women breastfeeding mothers.

Language: Английский

Covid-19 vaccination in pregnancy DOI Open Access
Martina L. Badell, Carolynn M. Dude, Sonja A. Rasmussen

et al.

BMJ, Journal Year: 2022, Volume and Issue: unknown, P. e069741 - e069741

Published: Aug. 10, 2022

ABSTRACT Pregnancy is an independent risk factor for severe covid-19. Vaccination the best way to reduce SARS-CoV-2 infection and limit its morbidity mortality. The current recommendations from World Health Organization, Centers Disease Control Prevention, professional organizations are pregnant, postpartum, lactating women receive covid-19 vaccination. specific considerations involve potential effects of vaccination on fetal development, placental transfer antibodies, safety maternal Although pregnancy was exclusion criterion in initial clinical trials vaccines, observational data have been rapidly accumulating thus far confirm that benefits outweigh risks. This review examines evidence supporting effectiveness, immunogenicity, transfer, side effects, perinatal outcomes Additionally, it describes factors associated with vaccine hesitancy pregnancy. Overall, studies monitoring people who received vaccines during not identified any concerns. Additional information non-mRNA early pregnancy, longer term infants needed. To collect this information, must be prioritized research.

Language: Английский

Citations

98

COVID-19 vaccination hesitancy and willingness among pregnant women in Italy DOI Creative Commons
Grazia Miraglia del Giudice, Lucio Folcarelli, Annalisa Napoli

et al.

Frontiers in Public Health, Journal Year: 2022, Volume and Issue: 10

Published: Oct. 3, 2022

Pregnant women, especially those with comorbidities, compared to non-pregnant, have higher risk of developing a severe form COVID-19. However, COVID-19 vaccine uptake is very low among them.An anonymous questionnaire was administered randomly selected women 18 years age that were currently pregnant or had just given birth between September 2021 and May 2022 in the geographic area Naples. Vaccine hesitancy assessed using scale (VHS).A total 385 participated. Women who not been infected by SARS-CoV-2 needed information about vaccination against perceived being SARS-CoV-2. More than half (54.3%) afraid potential side effects on fetus. There concern fetus did graduate degree, high-risk pregnancy, SARS-CoV-2, more concerned they could be know this recommended for them, trusting mass media/internet/social networks information. Only 21.3% vaccinated when pregnant, mostly university before need information, acquired from gynecologists. Almost three-quarters (71.9%) willing receive likely at least one relative/cohabitant partner/friend extremely A 86.4% highly hesitant. Highly hesitant respondents get less information.Public health efforts education campaigns are changing their perception patterns supporting gynecologists promoting vaccination.

Language: Английский

Citations

45

Influence of the COVID-19 pandemic and social media on the behaviour of pregnant and lactating women towards vaccination: a scoping review DOI Creative Commons
Larissa De Brabandere, Greet Hendrickx, Karolien Poels

et al.

BMJ Open, Journal Year: 2023, Volume and Issue: 13(2), P. e066367 - e066367

Published: Feb. 1, 2023

Background Pregnant women, foetuses and infants are at risk of infectious disease-related complications. Maternal vaccination is a strategy developed to better protect pregnant women their offspring against morbidity mortality. Vaccines influenza, pertussis recently also COVID-19 widely recommended for women. Yet, there still significant amount hesitation towards maternal policies. Furthermore, contradictory messages circulating social media impact vaccine confidence. Objectives This scoping review aims reveal how impacted confidence in lactating Additionally, this studied the role plays creating opinions these target groups. Eligibility criteria Articles published between 23 November 2018 18 July 2022 that linked objectives were included. Reviews, articles not focusing on group, abstracts, describing outcomes infection/COVID-19 excluded. Sources evidence The PubMed database was searched select articles. Search terms used pregnancy, lactation, vaccination, hesitancy, media. Charting methods Included abstracted synthesised by one reviewer. Verification done second Disagreements addressed through discussion reviewers other researchers. Results generally less likely accept compared with non-pregnant non-nursing main reason refuse safety concerns. A positive link detected willingness acceptance vaccines during pregnancy. internet identified as important information sources vaccination. Discussion conclusion Vaccine hesitancy remains an issue, expressing need effective interventions increase coverage. uptake unclear.

Language: Английский

Citations

24

The risk of miscarriage following COVID-19 vaccination: a systematic review and meta-analysis DOI Creative Commons
Michael P. Rimmer, Jhia Jiat Teh, Scott C. Mackenzie

et al.

Human Reproduction, Journal Year: 2023, Volume and Issue: 38(5), P. 840 - 852

Published: Feb. 16, 2023

Abstract STUDY QUESTION What is the risk of miscarriage among pregnant women who received any COVID-19 vaccines? SUMMARY ANSWER There no evidence that vaccines are associated with an increased miscarriage. WHAT IS KNOWN ALREADY In response to pandemic, mass roll-out helped boost herd immunity and reduced hospital admissions, morbidity, mortality. Still, many were concerned about safety for pregnancy, which may have limited their uptake those planning a pregnancy. DESIGN, SIZE, DURATION For this systematic review meta-analysis, we searched MEDLINE, EMBASE, Cochrane CENTRAL from inception until June 2022 using combination keywords MeSH terms. PARTICIPANTS/MATERIALS, SETTING, METHODS We included observational interventional studies enrolled evaluated available compared placebo or vaccination. primarily reported on in addition ongoing pregnancy and/or live birth. MAIN RESULTS AND THE ROLE OF CHANCE data 21 (5 randomized trials 16 studies) reporting 149 685 women. The pooled rate vaccine was 9% (n = 14 749/123 185, 95% CI 0.05–0.14). Compared vaccination, did not higher (risk ratio (RR) 1.07, 0.89–1.28, I2 35.8%) had comparable rates birth (RR 1.00, 0.97–1.03, 10.72%). LIMITATIONS, REASONS FOR CAUTION Our analysis varied reporting, high heterogeneity bias across studies, limit generalizability confidence our findings. WIDER IMPLICATIONS FINDINGS increase reproductive age. current remains larger population needed further evaluate effectiveness vaccination FUNDING/COMPETING INTEREST(S) No direct funding provided support work. M.P.R. funded by Medical Research Council Centre Reproductive Health Grant No: MR/N022556/1. B.H.A.W. hold personal development award National Institute UK. All authors declare conflict interest. REGISTRATION NUMBER CRD42021289098.

Language: Английский

Citations

24

Knowledge, Attitude, Acceptance, and Perceived Risks of COVID-19 Vaccines among Pregnant Women: Findings and Implications DOI Open Access
Steward Mudenda,

Gastone Tembo,

Ruth Lindizyani Mfune

et al.

SAS Journal of Medicine, Journal Year: 2024, Volume and Issue: 10(01), P. 9 - 19

Published: Jan. 2, 2024

Introduction: COVID-19 vaccines are essential in reducing symptoms and severity of the disease as well preventing infection with COVID-19. Vaccination pregnant women against has been recommended globally. In Zambia, there is a paucity information on knowledge, attitude, acceptance, perceived risks among women. Therefore, this study assessed vaccination attending antenatal care at Women Newborn Hospital (WNH) University Teaching Hospitals (UTHs) Lusaka, Zambia. Methods: This was descriptive cross-sectional conducted from August 2023 to October 300 Data were collected using structured questionnaire analysed Statistical Package for Social Science (SPSS) version 23.0. The Chi-square test used relationship between dependent independent variables. statistical significance 95% confidence level. Results: Of participants, 186 (62.0%) aged 24 34 years 185 (61.5%) aware that vaccine pregnancy. Overall, 284 (94.7%) had good 258 (86.0%) positive vaccinated. Additionally, 20 (17.5%) who not vaccinated willing be Furthermore, most participants felt safe use results show lower acceptance compared knowledge attitude levels. Having associated education status (X^2=33.011, p=0.001 level) (X^2=9.132, p=0.029 level). Conclusion: found WNH attitudes, perceptions, high ..........

Language: Английский

Citations

6

A scoping review of global COVID-19 vaccine hesitancy among pregnant persons DOI Creative Commons

Imaima Casubhoy,

Alyssa M. Kretz,

Heang-Lee Tan

et al.

npj Vaccines, Journal Year: 2024, Volume and Issue: 9(1)

Published: July 20, 2024

Abstract Uptake of the COVID-19 vaccine among pregnant persons is lower than general population. This scoping review explored people’s attitudes towards vaccine, reasons for hesitancy, and whether about vaccines differ by country origin. A was conducted across PubMed, Embase, CINHAL, Scopus. Inclusion criteria were articles published in English from 2019–2022 focused on vaccination persons. Data analysis done via 5Cs framework hesitancy: Constraints, Complacency, Calculation, Confidence, Collective Responsibility. 44 extracted. lack confidence safety most prevalent theme hesitancy largely driven a access to information as well mistrust medical professionals. Meanwhile, acceptance mostly desire protect themselves their loved ones. Overall, continues be high. Vaccine primarily fear unknown side effects fetuses along with mistrust. Some differences can seen between high income low- middle-income countries regarding showing that single solution cannot applied all who are hesitant. General strategies, however, utilized reduce including advocating inclusion clinical trials incorporating consistent counseling during prenatal appointments.

Language: Английский

Citations

6

COVID-19 vaccine hesitancy among Nigerians living with non-communicable diseases: a qualitative study DOI Creative Commons
Lucia Yetunde Ojewale, Ferdinand C. Mukumbang

BMJ Open, Journal Year: 2023, Volume and Issue: 13(2), P. e065901 - e065901

Published: Feb. 1, 2023

The discovery and subsequent manufacture of various types COVID-19 vaccines were considered a breakthrough in the fight against pandemic. Initially, limited supplies warranted vulnerable populations such as people living with chronic non-communicable diseases elderly to be prioritised for vaccination. Nevertheless, uptake among these was suboptimal. In this study, we aimed describe drivers vaccine hesitancy Ibadan, Nigeria.We applied qualitative methods explore feelings thoughts towards vaccines, at tertiary hospital Nigeria. Data obtained from 25 conditions through in-depth interviews. We thematically analysed transcripts inductively deductively. Dedoose data management software used manage data.Emerging subthemes grouped into two major themes: Hesitancy related biological concerns those sociopolitical issues. associated factors included: (1) over worsening underlying condition; (2) fear harmful physiological consequences; (3) insufficient testing safety (4) perceived infectiveness. Sociopolitical misconceptions treatment COVID-19; mistrust manufacturers ('the whites'); government misinformation.Public health education on nature benefits is urgently needed diseases. These measures could improve healthcare usage general. Paying attention have implications next global pandemic requiring mass

Language: Английский

Citations

10

Attitudes towards vaccination against COVID-19 during pregnancy and its determinants among people of reproductive age DOI Creative Commons
Chenyuan Qin,

Yansheng Ding,

Min Liu

et al.

Human Vaccines & Immunotherapeutics, Journal Year: 2025, Volume and Issue: 21(1)

Published: Jan. 11, 2025

The attitudes of reproductive-age individuals toward COVID-19 vaccination during pregnancy are still not well understood. We aimed to explore the vaccines and determinants among Chinese population. An anonymous cross-sectional study was conducted in China from July 4 August 11, 2023. Structured questionnaires on vaccine hesitancy pregnancy, socio-demographic characteristics, behavior health-related factors, mental health status were sent online (both males females). Among 2966 participants reproductive age, 86.9% exhibited significant receiving pregnancy. Participants older age (30–34: aOR = 1.71, 95% CI: 1.62–2.52; 35–39: 1.72, 1.11–2.66), nonsmokers (aOR 1.42, 1.07–1.89), with a longer duration since their last 2.37, 1.20–4.70), exhibiting marked pandemic fatigue (moderate: 1.98, 1.56–2.52; high: 3.49, 2.41–5.05) prone refuse presence generalized anxiety disorder may push 0.75, 0.57–0.99). top three reasons for hesitation concerns about adverse effects pregnant women (77.72%), fetuses (72.13%), newborns/infants (58.77%), respectively. Therefore, under context existing circumstances WHO's encouragement, this provides data support possible future policy changes emphasizes importance public strategies.

Language: Английский

Citations

0

Pregnant women's experiences of and attitudes toward COVID-19 vaccination: A qualitative descriptive study DOI Creative Commons
Hee Sun Kang, So Youn Kim, Jennie C. De Gagné

et al.

Vaccine, Journal Year: 2025, Volume and Issue: 50, P. 126835 - 126835

Published: Feb. 6, 2025

Language: Английский

Citations

0

COVID-19 vaccination rates among pregnant women in France: A nationwide cohort study DOI Creative Commons

Cécilia Bernard,

Jérôme Drouin, Stéphane Le Vu

et al.

Vaccine, Journal Year: 2025, Volume and Issue: 53, P. 127070 - 127070

Published: April 1, 2025

Pregnant women are at an elevated risk for severe COVID-19, but nationwide rates of vaccination and its timing during pregnancy not well documented in France. To assess COVID-19 among pregnant France, compare them to those the general population, analyse factors associated with status timing. A study using EPI-MERES register, which includes all 1,203,454 who delivered between April 2021 December 2022 Standardization by age social index was used female population. Associations sociodemographic factors, monitoring indicators, pre-existing comorbidities were measured multivariable logistic regression. Overall, 52 % received least one vaccine dose, 62.1 vaccinated before conception 8.2 %, 20.9 8.8 1st, 2nd, 3rd trimester, respectively. Vaccination initially lagged behind population converged June 2022, a six-month lag. Younger more socially deprived less highly vaccinated. Unvaccinated likely be their third (aOR, 1.21 [1.19-1.22]), had fewer ultrasound scans 0.71 [0; 70-0.73]), often took folic acid 0.73 [0.72-0.74]). Women comorbidities, such as obesity, diabetes, hypertension, antidepressant use, or chronic respiratory disease, unvaccinated (aORs ranged from 0.69 0.89). France than crucial pandemic periods eventually reached similar rates. Socioeconomic level prenatal care strongly low uptake. This should focus future interventions policy adjustments across segments this

Language: Английский

Citations

0